SP-42

N/A

Report date: 2022/11/24 12:05:11

Base Information

Drug NameSP-42
Drug Alias NameSP-42 LiposomeSTEALTH (YIGSR peptide)SP-42SPI-42
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursAngiogenesis disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSequus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSequus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursAngiogenesis disorder

Other Information

ATC CodeN/A
Related LinksN/A